Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011053 (
deafness
)
10,271
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Congenital deafness accounts for about 1 in 1000 infants and approximately 80% of cases are inherited as an autosomal recessive trait. Recently, it has been demonstrated that
connexin 26
(
GJB2
) gene is a major gene for congenital sensorineural
deafness
. A single mutation (named 35delG) was found in most recessive families and sporadic cases of congenital deafness, among Caucasoids, with relative frequencies ranging from 28% to 63%. We present here the analysis of the 35delG mutation in 3270 random controls from 17 European countries. We have detected a carrier frequency for 35delG of 1 in 35 in southern Europe and 1 in 79 in central and northern Europe. In addition, 35delG was detected in five out of 376 Jewish subjects of different origin, but was absent in other non-European populations. The study suggests either a single origin for 35delG somewhere in Europe or in the Middle East, and the possible presence of a carrier advantage together with a founder effect. The 35delG carrier frequency of 1 in 51 in the overall European population clearly indicates that this genetic alteration is a major mutation for autosomal recessive
deafness
in Caucasoids. This finding should facilitate diagnosis of congenital deafness and allow early treatment of the affected subjects.
...
PMID:High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. 1131 51
Deafness
is the most common sensory defect. The investigation of the cause of
deafness
is critical for genetic counselling, and sometimes for appropriate management of associated pathologies. About two thirds of cases of congenital deafness are genetic forms, and the proportion is probably similar concerning the forms of
deafness
that appears during childhood. Some of the genetic forms are syndromic and the associated signs are sometimes inapparent or may appear during childhood. Consequently, a systematic search for the most frequent syndromes is necessary in each deaf individual. In the majority of genetic cases,
deafness
is the sole defect (non-syndromic
deafness
) and the major mode of transmission is autosomal recessive. The DFNB1 form of
deafness
, due to
connexin 26
gene mutations, underlies half of the cases of non syndromic congenital deafness cases. The hearing loss has a prelingual onset, and it is most frequently severe or profound. There is no associated pathologies or radiological anomalies of the inner ear, and the vestibular tests are normal. The possibility of offering molecular diagnosis of
connexin 26
gene defects is profoundly modifying daily medical practice in the investigation of the cause of
deafness
.
...
PMID:[Hereditary sensorineural deafness]. 1073 85
Recently, mutations in two gap junction genes,
GJB2
and GJB3 (encoding Connexin 26 and Connexin 31, respectively), have been shown to underlie either inherited hearing loss and skin disease or both disorders. In this study, we have extended our analysis of a small family in which palmoplantar keratoderma and various forms of
deafness
is segregating. In addition to the previously described sequence variant M34T in
GJB2
, two other sequence variants were identified: D66H also in
GJB2
and R32W in GJB3. As D66H segregated with the skin disease, it is likely to underlie the palmoplantar keratoderma. The other two gap junction variants identified may contribute to the type of hearing impairment and the variable severity of the skin disease in the family.
...
PMID:Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. 1117 5
Hearing impairment, defined as > or = 40 dB hearing loss, is the most prevalent sensory handicap, present in 1:750 children and in 4-36% of adults, depending on age. Genetic factors are of major importance in more than 50% of all hearing loss. An important distinction is made between syndromic
deafness
and isolated
deafness
depending on the presence or not of associated manifestations from other organs. The knowledge about genetic
deafness
has increased dramatically in the last few years. As of March 1999, at least 53 loci for isolated
deafness
of different types of monogenic inheritance have been identified. Suspected genetic heterogeneity has thus been confirmed. At least 15 genes for syndromic
deafness
have been cloned, leading to increased biological insight in shared developmental pathways in different species and leading to better diagnostic tools applicable to patients. The identification of a particularly frequent mutation in a gap junction gene,
GJB2
(connexin 26), may turn out to be of particular diagnostic importance in the aetiological evaluation of childhood
deafness
even in isolated cases. Application of early screening tests, like otoacoustic emission (OAE), in combination with genetic tests will facilitate early and specific diagnosis of hearing impairment and thereby improve audiological rehabilitation. Syndromic
deafness
involves all organs, and care for and evaluation of affected individuals should be a multiprofessional task.
...
PMID:[Genetic causes of hearing loss--status and perspectives]. 1085 Jan 95
Mutations in the CX26 gene (
GJB2
), encoding the gap-junction protein Connexin-26, have been shown to be the major cause of non-syndromic recessive
deafness
. Among these mutations, the deletion of a guanine within the stretch of six G between nucleotide positions +30 and +35 of the CX26 cDNA (30delG) accounts for the majority of this kind of
deafness
. Molecular detection of the 30delG mutation is usually performed by direct sequencing analysis of PCR products or by SSCP. To detect this mutation we developed an easy and reliable method, based on PCR, followed by a non-radioactive sandwich hybridization on microtiter plates. We tested 188 individuals recruited from the genetic counseling service for deaf people at the Pasteur Hospital and at the Armand-Trousseau Children's Hospital, Paris, France between April 1997 and September 1998. Our screening method is simple, uses stable and safe reagents, and employs inexpensive equipment. As such, it is suitable for widespread use in genetic diagnosis.
...
PMID:A simple and reliable method for the detection of the 30delG mutation of the CX26 gene. 1086 Jul 12
The
GJB2
(connexin 26) gene, one of the major genes responsible for autosomal recessive
deafness
, has been investigated previously by a variety of techniques, including PCR-SSCP and sequencing of the entire gene for screening of unknown mutations, and allele-specific PCR, ASO, and PCR-mediated site-directed mutagenesis for the detection of the common mutation 35delG. Here, we present the development of a DGGE method for the characterization of the full spectrum of mutations in the
GJB2
gene. The
GJB2
cDNA and flanking sequences were amplified in three overlapping segments. We screened 26 Greek patients with prelingual, sensorineural
deafness
, where syndromic forms and environmental causes of
deafness
had been excluded. The 35delG mutation was detected in 28 chromosomes (53.8%), while another three sequence variations accounted for 7.6% of the alleles. The sequence variation R127H, previously described in a few Spanish and Balkan patients, was detected in two patients as the sole mutation. A novel sequence variation, K224Q, was identified as the sole mutation in one patient. Use of this approach may contribute to the full description of mutations in this important
deafness
gene.
...
PMID:Mutation analysis of the GJB2 (connexin 26) gene by DGGE in Greek patients with sensorineural deafness. 1087 98
Recently, mutations in two gap junction genes,
GJB2
and GJB3 (encoding Connexin 26 and Connexin 31, respectively), have been shown to underlie either inherited hearing loss and skin disease or both disorders. In this study, we have extended our analysis of a small family in which palmoplantar keratoderma and various forms of
deafness
is segregating. In addition to the previously described sequence variant M34T in
GJB2
, two other sequence variants were identified: D66H also in
GJB2
and R32W in GJB3. As D66H segregated with the skin disease, it is likely to underlie the palmoplantar keratoderma. The other two gap junction variants identified may contribute to the type of hearing impairment and the variable severity of the skin disease in the family.
...
PMID:Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. 1075 47
Previous studies of the gap-junction beta-2 subunit gene
GJB2
(connexin 26) have suggested that the 101T-->C (M34T) nucleotide substitution may be a mutant allele responsible for recessive
deafness
DFNB1. This hypothesis was consistent with observations of negligible intercellular coupling and gap-junction assembly of the M34T allele product expressed in Xenopus oocytes and HeLa cells. The results of our current study of a family cosegregating the 167delT allele of
GJB2
and severe DFNB1
deafness
demonstrate that this phenotype did not cosegregate with the compound-heterozygous genotype M34T/167delT. Since 167delT is a null allele of
GJB2
, this result indicates that the in vivo activity of a single M34T allele is not sufficiently reduced to cause the typical
deafness
phenotype associated with DFNB1. This observation raises the possibility that other
GJB2
missense substitutions may not be recessive mutations that cause severe
deafness
and emphasizes the importance of observing cosegregation with
deafness
in large families to confirm that these missense alleles are mutant DFNB1 alleles.
...
PMID:Autosomal recessive nonsyndromic neurosensory deafness at DFNB1 not associated with the compound-heterozygous GJB2 (connexin 26) genotype M34T/167delT. 1090 23
Geographically isolated populations have been successfully used to localize genes for recessive inherited diseases, including non-syndromic sensorineural recessive
deafness
(NSRD). To date, 25 loci for NSRD have been localized on human chromosomes (DFNB loci), and six of the corresponding genes have been identified. Here, we report on the contribution of the DFNB1 locus (
GJB2
gene) to NRSD in seven affected families living in three northern Tunisian geographic isolates, and we provide evidence for genetic heterogeneity within isolates. This finding challenges the classical view of a single 'founder' mutation segregating in such isolates.
...
PMID:Mutations of GJB2 in three geographic isolates from northern Tunisia: evidence for genetic heterogeneity within isolates. 1090 64
Congenital deafness is a very frequent disorder occurring in approximately I in 1000 live births. Mutations in
GJB2
encoding for gap junction protein connexin-26 (Cx26) have been established as the basis of autosomal recessive non-syndromic hearing loss and proposed in some rare cases of autosomal dominant form of
deafness
. Connexin are gap-junction proteins which constitute a major system of intercellular communication important in the exchange of electrolytes, second messengers and metabolites. In the inner ear,
connexin 26
expression was demonstrated in the stria vascularis, basement membrane, limbus and the spiral prominence of the human cochlea. The loss of
connexin 26
in the gap junction complex would expect to disrupt the recycling of potassium from the synapses at the base of hair cells through the supporting cells and fibroblasts of potassium ions back to the high potassium containing endolymph of the cochlear duct and therefore would result in a local intoxication of the Corti s organ by potassium, leading to the hearing loss. The discovery of the genes responsible of hearing loss in particular the identification of mutations in the gene coding for
connexin 26
allows to hope some tremendous help in genetic counseling. The possible implication of the mutation of the connexin gene in the pathophysiology of some progressive adult
deafness
opens new prospects in the fine diagnostic of the ear diseases and eventually may lead to new therapeutic strategies applied to the cochlea.
...
PMID:Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 gene. 1092 3
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>